Novavax Inc (NVAX)

[senderos]

I have to admit that this is looking good. Up 10% yesterday on almost double the normal volume. I bought back in yesterday at $1.90. Bring on that news, and let's see what happens.

"In September 2017, we initiated a Phase 1/2 clinical trial of our nanoparticle seasonal influenza vaccine candidate including our proprietary Matrix-M adjuvant (“NanoFlu™”) in older adults. The trial is a randomized, observer-blinded, active comparator-controlled trial in approximately 330 healthy older adults. The primary objective of the trial is to assess the safety and immunogenicity of two concentrations (15 µg or 60 µg) of NanoFlu compared to a licensed influenza vaccine, Fluzone® High-Dose (“Fluzone HD”). Data from the trial are expected by February 2018."